A newly formed group of vaccine advisors, appointed by Health Secretary Robert F. Kennedy Jr., is set to evaluate several immunization policies in an upcoming session, including a vote on flu vaccines that use thimerosal, a mercury-based preservative. They will also consider guidance related to the measles vaccine.
The panel, which provides recommendations to the Centers for Disease Control and Prevention, will meet on June 25 and 26. According to a preliminary schedule published on the CDC’s website, members will also vote on eligibility guidelines for receiving vaccines targeting respiratory syncytial virus (RSV) and influenza.
One key topic for the meeting includes a discussion on whether the combined measles, mumps, rubella, and varicella (MMRV) vaccine should be administered to children under the age of five.
As of now, the agenda does not list specific individuals who will be speaking about either MMRV or thimerosal during the proceedings.
The CDC notes that thimerosal has been used in the United States for decades, particularly in multi-dose vials of vaccines and other medications.

{Matzav.com}